The number of deaths from colorectal cancer in Japan continues to increase. Colorectal
cancer deaths exceeded 50,000 in 2016. In the 2019 edition, revision of all aspects of …

The lungs are the second most common site of metastasis for colorectal cancer (CRC) after
the liver. Rectal cancer is associated with a higher incidence of lung metastases compared …

Main indications of percutaneous pulmonary thermal ablation are early stage non-small cell
lung carcinoma (NSCLC) for patients who are not amenable to surgery and slow-evolving …

Radiofrequency of lung metastases below 4 cm, demonstrated an overall survival of 62
months, associated with a 4-year local efficacy of 89%. Repeatability of the technique allows …

Background Although radiofrequency ablation (RFA) is widely performed for the treatment of
colorectal cancer (CRC) lung metastases, its efficacy for candidates with surgically …

Background Colorectal cancer (CRC) is the third most common malignant neoplasm
worldwide and the fourth leading cause of cancer-related deaths. This article reviews the …

Background This study investigated recent clinical outcomes and prognostic factors of
metastasectomy for pulmonary metastasis (PM) from colorectal cancer. Methods Data for …

Background Ionic liquid (IL) pretreatment could enable an economically viable route to
produce biofuels by providing efficient means to extract sugars and lignin from …

Purpose: We have reported loss of SMAD4 promotes expression of CCL15 from colorectal
cancer to recruit CCR1+ myeloid cells through the CCL15-CCR1 axis, which contributes to …

Colorectal cancer (CRC) is a frequently occurring disease, yet diagnosed at a local stage in
only 40% of cases. Lung metastases (LM) appear in 5–15% of patients and, left untreated …